← All US exec pay
Taysha Gene Therapies, Inc. (TSHA)
CEO compensation · Materials · FY2025
Versus Materials peers
Sean Nolan's FY2025 total of $4.10M ranks at the
48.9th percentile
among 326 sector CEOs · sector median $4.22M · p75 $8.65M.
CEO pay mix
CEO total comp over time
Named Executive Officers — FY2025
| Executive | Title | Salary | Bonus | Stock | Option | Incentive | Other | Total | Source |
|---|
| Sean Nolan |
CEO |
$0.65M | — | — |
— | $0.54M | $0.00M |
$4.10M |
SEC ↗ |
| Kamran Alam |
CFO |
$0.47M | — | — |
— | $0.27M | $0.00M |
$2.15M |
SEC ↗ |
| Sukumar Nagendran |
M.D. President and Head of Research and Development and Director |
$0.61M | — | — |
— | $0.43M | $0.00M |
$2.09M |
SEC ↗ |
Every figure links to its source SEC proxy (DEF 14A). Extraction: edgartools/ECD-XBRL.